Securities code: 002755 securities abbreviation: Beijing Aosaikang Pharmaceutical Co.Ltd(002755) Announcement No.: 2022-005 Beijing Aosaikang Pharmaceutical Co.Ltd(002755)
Announcement on resolutions of the 17th meeting of the 5th board of supervisors
The company and all members of the board of supervisors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
The 17th meeting of the 5th board of supervisors of Beijing Aosaikang Pharmaceutical Co.Ltd(002755) (hereinafter referred to as “the company”) was notified to all supervisors by telephone and personal communication on January 13, 2022. The meeting was held on January 21, 2022 in conference room 3102, building a, No. 699, Kejian Road, Jiangning Science Park, Nanjing.
Three supervisors should be present at this meeting, and three actually present. This meeting complies with the company law of the people’s Republic of China (hereinafter referred to as the “company law”), the securities law of the people’s Republic of China (hereinafter referred to as the “Securities Law”) and other laws, administrative regulations, departmental rules, normative documents and the relevant provisions of the articles of association.
The meeting was presided over by Mr. Chen Jing, chairman of the board of supervisors. After careful deliberation by the participating supervisors, the following resolutions were unanimously reached: I. the proposal on the general election of the board of supervisors and the nomination of non employee representative supervisors of the sixth board of supervisors of the company was deliberated and adopted
The term of office of the Fifth Board of supervisors of the company will expire on February 18, 2022. The general election shall be conducted in accordance with the company law, the stock listing rules of Shenzhen Stock Exchange, the guidelines for the standardized operation of listed companies of Shenzhen Stock Exchange and other laws, regulations, normative documents and the relevant provisions of the articles of association. There are 3 members of the sixth board of supervisors of the company, including 1 non employee representative supervisor and 2 employee representative supervisors, with a term of office of three years. Upon the recommendation of the board of supervisors of the company, it is agreed to nominate Chen Jing as the candidate of non employee representative supervisor of the sixth board of supervisors.
After the deliberation and approval of the first extraordinary general meeting of shareholders in 2022, the above candidates will form the sixth board of supervisors together with the employee representative supervisors elected by the employee congress of the company.
Among the aforesaid candidates for non employee representative supervisors and employee representative supervisors elected by the employee congress, those who have served as directors or senior managers of the company in the last two years shall not exceed half of the total number of supervisors of the company; The number of supervisors nominated by a single shareholder shall not exceed half of the total number of supervisors of the company.
Voting results: 3 in favor, 0 against and 0 abstention.
The specific contents of the announcement on the general election of the board of supervisors of the company are published in the securities times, securities daily and cninfo on the same day（ http://www.cn.info.com.cn. ）Company announcement on (Announcement No.: 2022-007).
This proposal needs to be submitted to the first extraordinary general meeting of shareholders in 2022 for deliberation.
2、 Documents for future reference
Resolution of the 17th meeting of the 5th board of supervisors
It is hereby announced.
Beijing Aosaikang Pharmaceutical Co.Ltd(002755) board of supervisors January 21, 2022
